Printer Friendly

MICROBIOLOGICAL ASSOCIATES BECOMES FIRST CERTIFIED PROVIDER OF INVITRO INTERNATIONAL TEST SYSTEMS

         MICROBIOLOGICAL ASSOCIATES BECOMES FIRST CERTIFIED
            PROVIDER OF INVITRO INTERNATIONAL TEST SYSTEMS
    IRVINE, Calif., July 8 /PRNewswire/ -- InVitro International (IVI) (NASDAQ: INVI) announced today the signing of a major contract laboratory agreement with Microbiological Associates Inc. (MA) as the first of a limited number of certified providers of such products as EYTEX, SKINTEX and SOLATEX.
    Microbiological Associates, with laboratories located in Rockville, Md., and Stirling, Scotland, is a privately held company providing testing services throughout the United States, Europe and Japan.  MA has been a leading provider of short-term biological safety testing for more than 40 years.  The company evaluates cosmetic and personal care products, household products, agricultural chemicals and biotherapeutics for more than 400 of the world's leading corporations and research institutes.  MA is considered the market leader in the provision of both in vitro toxicology and biosafety testing services.
    William Fisher, IVI's president, stated, "As science progresses, in vitro technology will fill a vital role in formulation, competitive analysis and many other product testing uses.  We feel that Microbiological Associates and InVitro International are similarly positioned in their respective fields as leaders.  Subsequently, this association is one which will serve our mutual customers very well."
    InVitro International is the recognized worldwide leader in the new area of in vitro safety testing and produces proprietary tests to evaluate potential irritation to humans posed by a wide variety of chemicals and compounds.  Its tests provide a cost effective, rapid and consistent laboratory alternative to live animal testing, enabling household, consumer and industrial products manufacturers to screen new materials and products formulations to assess their safety.  The company also markets throughout North America, Europe and the Pacific Rim and has staff operations in Paris and Tokyo.
    -0-                  7/8/92
    /CONTACT:  Fran Daniels of Financial Sciences of America, 310-278-4413, for InVitro International/
    (INVI) CO:  InVitro International; Microbiological Associates Inc. ST:  California IN:  MTC SU:  CON CH -- NYON1 -- 7288 07/08/92 09:02 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 8, 1992
Words:322
Previous Article:BRAJDAS CORP. ANNOUNCES FINANCIAL RESULTS
Next Article:AT&T OFFERS CALLING PROMOTION TO CELEBRATE BASTILLE DAY
Topics:


Related Articles
INVITRO INTERNATIONAL ANNOUNCES RESULTS FOR SECOND QUARTER AND SIX MONTHS ENDED MARCH 31, 1992
CONTROLS FOR ENVIRONMENTAL POLLUTION EXPANDS LAB TESTING SERVICES WITH INVITRO TEST FOR CORROSIVITY
INVITRO INTERNATIONAL SIGNS AGREEMENT TO EXCLUSIVELY LICENSE DNA IDENTIFICATION PRODUCTS
INVITRO INTERNATIONAL SIGNS DISTRIBUTION AGREEMENTS WITH FIVE NEW SALES AGENTS IN EUROPE
INVITRO INTERNATIONAL REPORTS SECOND QUARTER RESULTS
INVITRO INTERNATIONAL ANNOUNCES JOINT MARKETING VENTURE WITH BURLINGTON RESEARCH
InVitro International Reports First Quarter Results
InVitro International and Miragen Sign Amended Letter of Intent
InVitro International Reports Second Quarter Results and Comments on Annual Meeting: Company Looks Forward with Cautious Optimism
Standards Institute of Israel (SII) Accepts NSF Certification For New Israeli Water Filter Import Regulations.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters